Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Medicine by Design’s 5th Annual Symposium will bring together principal investigators and trainees from across the University of Toronto and its affiliated hospitals, members of our Scientific Advisory Board, representatives from our ecosystem partners across industry, the investment community, government and the not-for-profit sector, and international collaborators to advance our research toward impact.
The theme of this year’s virtual symposium is Better Science through Convergence. Through talks by invited speakers from across North America and Medicine by Design principal investigators, we will highlight how collaboration and convergence across research disciplines are accelerating regenerative medicine discoveries and translation. We will also hold a virtual poster session featuring the research of select trainees working on Medicine by Design-funded projects.
Please visit, https://mbd.utoronto.ca/event/5th-annual-medicine-by-design-symposium/, for more info on registration and program.